Catalyst Pharmaceuticals Inc. (CPRX)

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

AbbVie Inc. (ABBV $220.08)
- $220.08 P/E (TTM): 168.0X Cap: $388.96B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $1,063.56)
- $1,063.56 P/E (TTM): 52.03X Cap: $1T
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $15.46)
- $15.46 P/E (TTM): 16.64X Cap: $392M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $72.47)
- $72.47 P/E (TTM): 16.58X Cap: $8.52B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $25.32)
- $25.32 Cap: $1.40B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $22.72)
- $22.72 P/E (TTM): 13.21X Cap: $2.79B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Q: What's your opinion about these two stocks? Buy/Hold/Sell? Timeframe: 3-5 years. Risk tolerance: moderate.

Read Answer Asked by Paul on September 12, 2025

Q: Are there any news or downgrades for CPRX? It's down 3.5% on the up day. Do you still like/recommend this stock for healthcare holdings?

Read Answer Asked by Anit on August 26, 2025